| Financial Year |
March 31 2022 |
| Monetary Funds |
117,540,355.77 |
| Held-for-trading Financial Assets |
85,143,377.40 |
| Notes Receivable |
7,380,261.21 |
| Accounts Receivable |
145,787,209.76 |
| Advances to Suppliers |
8,383,817.26 |
| Other Receivables |
3,150,002.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
28,694,475.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,169,563.19 |
| Total Current Assets |
398,249,062.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
59,793,573.51 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,759,681.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
9,141,609.41 |
| Other Non-Current Assets |
54,643,422.87 |
| Sub-Total of Non-Current Assets |
152,006,996.02 |
| Total Assets |
550,256,058.63 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,768,555.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,336,767.28 |
| Taxes Payable |
842,479.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,218,437.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,944,688.04 |
| Other Current Liabilities |
107,096.25 |
| Sub-Total of Current Liabilities |
11,642,675.37 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,886,843.82 |
| Total Liabilities |
15,529,519.19 |
| Paid-In Capital(Or Share Stock) |
362,314,440.00 |
| Capital Surplus |
24,260,150.10 |
| Surplus Reserve |
23,233,434.63 |
| LESS:Treasury Stock |
30,396,555.27 |
| Undistributed Profits |
124,301,404.04 |
| Minority Stockholder's Interest |
7,940,269.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
526,786,270.38 |
| Owner's Equity（Stockholder's Equity） |
534,726,539.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
550,256,058.63 |
